MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

METHOD AND KIT FOR RAPID DETECTION OF BRUCELLA SPP

Fundación Progreso y Salud
kit for the easy and rapid and detection of Brucella spp. This method is highly sensitive and specific and is based on the detection of a DNA-specific fragment through RT-PCR. The test of detection may be carried out in only 45min.

Full description

Brucellosis is the most spread zoonosis in the world. It is a high morbidity disease and constitutes a serious social and sanitary problem. It has a systemic activity and may affect nearly every organ in the body, causing a complex clinical syndrome which makes it often difficult to diagnose, especially in non-acute cases. The conventional methods of detection of Brucella spp. involve isolation and eventually culture of the isolated sample. This makes the available methods slow (days or even weeks) and burdensome, with the additional disadvantage of having a relatively low sensitivity and representing a considerable risk of infection for the laboratory staff. It is therefore a need to find new methods of detection of Brucella spp. which overcome the mentioned drawbacks.

The method here offered is a response to the instant needs. It consists of a method of detection of Brucella spp. based on the recognition of a particular DNA-fragment of the pathogen using a RT-PCR (Real Time Polymerase Chain Reaction).

A kit for the easy and rapid diagnosis of Tuberculosis and/or Brucellosis may be designed for carrying out the method.

Advantages of the offer

This new technique is DNA-specific and higly sensitive, thus constituting a very reliable method for the detection of Brucella spp. It further reduces operation times to only 45min. (related to days or even weeks in conventional methods) and is highly suitable for automation, thereby increasing reproducibility and reducing risks of infection of laboratory staff. The nature of the method makes it ideal for being carried out by means of a kit.

Domain of application

The method and the kit proposed may find extensive application in the field of diagnosis, allowing a rapid, easy, and reliable diagnosis of  Brucellosis.

Development status

Early Stage

Type of business relationship sought

The research group is looking for a collaboration agreement to further develop the technology or a licence agreement.

Patent number

IPR-Data : P200801280

Licensing contact

Gustavo Fúster Olagibel
Director
OTT-SSPA

Contact directly

Company details

Fundación Progreso y Salud

The Fundación Progreso y Salud is the central entity which supports and manages Public Health System research in Andalusia and also effectively promotes health research and innovation in the region.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us